# Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights

> **NCT00850590** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 48 (estimated)

## Conditions studied

- Incontinence

## Interventions

- **DRUG:** NRL001

## Key facts

- **NCT ID:** NCT00850590
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00850590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00850590, "Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00850590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*